These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 8330753)
1. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat. Smith SE; Meldrum BS Funct Neurol; 1993; 8(1):43-8. PubMed ID: 8330753 [TBL] [Abstract][Full Text] [Related]
2. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339 [TBL] [Abstract][Full Text] [Related]
3. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. DeGraba TJ; Ostrow P; Hanson S; Grotta JC J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322 [TBL] [Abstract][Full Text] [Related]
4. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. Graham SH; Chen J; Lan JQ; Simon RP J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416 [TBL] [Abstract][Full Text] [Related]
5. Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. Mies G; Kohno K; Hossmann KA J Cereb Blood Flow Metab; 1994 Sep; 14(5):802-7. PubMed ID: 8063875 [TBL] [Abstract][Full Text] [Related]
6. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Wrathall JR; Teng YD; Marriott R Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092 [TBL] [Abstract][Full Text] [Related]
7. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460 [TBL] [Abstract][Full Text] [Related]
8. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Wrathall JR; Teng YD; Choiniere D Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203 [TBL] [Abstract][Full Text] [Related]
9. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat. Hu P; Diemer NH; Bruhn T; Johansen FF J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493 [TBL] [Abstract][Full Text] [Related]
10. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Smith SE; Meldrum BS Stroke; 1992 Jun; 23(6):861-4. PubMed ID: 1595106 [TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance. Mares P; Mikulecká A; Pometlová M J Pharmacol Exp Ther; 1997 Jun; 281(3):1120-6. PubMed ID: 9190844 [TBL] [Abstract][Full Text] [Related]
12. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat. Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271 [TBL] [Abstract][Full Text] [Related]
13. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
15. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678 [TBL] [Abstract][Full Text] [Related]
16. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia. Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255 [TBL] [Abstract][Full Text] [Related]
18. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA. Yi JS; Kim YH; Koh JY Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485 [TBL] [Abstract][Full Text] [Related]
19. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. Nagayama M; Zhang F; Iadecola C J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187 [TBL] [Abstract][Full Text] [Related]
20. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]